NCT00465452View on ClinicalTrials.gov

Impact of Switching to Continuous Release Dopamine Agonists

PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2011

Conditions
Parkinson Disease
Interventions
DRUG

Continuous Release Dopamine Agonists

Continuous Release Dopamine Agonists

Trial Locations (1)

43614

Medical University of Ohio, Toledo

All Listed Sponsors
lead

University of Toledo

OTHER

NCT00465452 - Impact of Switching to Continuous Release Dopamine Agonists | Biotech Hunter | Biotech Hunter